EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Videoconference-Based Cognitive Behavioral Therapy in Medication-Treated Adults with Attention-Deficit/Hyperactivity Disorder: A Randomized, Assessor-Blinded, Controlled Trial

Aiko Eto, Ayumu Endo, Tokiko Yoshida, Yoichi Seki, Kayoko Taguchi, Minako Hongo, Kohei Takahashi, Yuki Shiko, Yoshiyuki Hirano, Eiji Shimizu

Psychotherapy and Psychosomatics · 05.06.2025 · 94 (5) · 343-357

DOI: 10.1159/000546539 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Psychotherapy and Psychosomatics, online erschienen am 05.06.2025. Verfasst von Aiko Eto und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cognitive Behavioral Physiology, Graduate School of Medicine, Chiba University, Chiba, Japan. Hauptthemen laut MEDLINE: Attention Deficit Disorder with Hyperactivity, Cognitive Behavioral Therapy, Videoconferencing. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 50 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder that frequently persists into adulthood. Pharmacotherapies are effective but have side effects and dropout risks. Videoconference-based cognitive behavioral therapy (vCBT) has emerged as a promising intervention, particularly for improving treatment accessibility. This study aimed to evaluate the efficacy of vCBT in adults with ADHD compared to treatment-as-usual (TAU) using a randomized, assessor-blinded, controlled trial design.

Methods

Thirty participants (aged 18–65 years) with ADHD were randomly assigned to either the 12-session individual vCBT intervention as an adjunct to TAU or TAU group. The primary outcome was the change in the total score on the ADHD Rating Scale-IV (ADHD-RS-IV) with adult prompts by a blinded assessor at 12 weeks from baseline. Secondary outcomes included self-reported measures of ADHD symptoms using the Conners’ Adult ADHD Rating-Self-Report, quality of life (QOL) using the Euro QOL 5 Dimension-5 Level, functional impairment using the Sheehan Disability Scale, depression, anxiety, and self-esteem.

Results

All of the participants received pharmacotherapy. Participants in the vCBT group (n = 15) demonstrated a significantly greater reduction in ADHD-RS-IV total score than those in the TAU group (vCBT −9.02 vs. TAU 0.84, p = 0.0007, effect size −1.46). Significant improvements in self-reported inattention, hyperactivity, impulsivity, QOL, and work/school performance were observed in favor of vCBT.

Conclusion

This study highlights the efficacy of vCBT as a viable and accessible intervention for adults with ADHD, particularly in reducing core symptoms and enhancing QOL and functional outcomes. vCBT is an important alternative treatment, especially for patients who remain symptomatic after pharmacotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Attention Deficit Disorder with HyperactivityCognitive Behavioral TherapyVideoconferencingHumansAdultMaleFemaleMiddle AgedTreatment OutcomeYoung AdultQuality of LifeAdolescentAgedSingle-Blind Method

Stichwörter der Autor:innen

Attention-deficit/hyperactivity disorderCognitive behavioral therapyCognitive therapyRandomized controlled trialVideoconference-based cognitive behavioral therapy

Autor:innen und Institutionen

  • Department of Cognitive Behavioral Physiology, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Research Center for Child Mental Development, Chiba University, Chiba, Japan.
  • Department of Psychology, Faculty of Letters, Komazawa University, Tokyo, Japan.
  • Cognitive Behavioral Therapy Center, Chiba University Hospital, Chiba, Japan.
  • United Graduate School of Child Development, The University of Osaka, Suita, Japan.
  • Biostatistics Section, Clinical Research Center, Chiba University Hospital, Chiba, Japan.

Zitieren

APA

Eto, A., Endo, A., Yoshida, T., Seki, Y., Taguchi, K., Hongo, M., Takahashi, K., Shiko, Y., Hirano, Y., & Shimizu, E. (2025). Videoconference-Based Cognitive Behavioral Therapy in Medication-Treated Adults with Attention-Deficit/Hyperactivity Disorder: A Randomized, Assessor-Blinded, Controlled Trial. Psychotherapy and Psychosomatics, 94(5), 343-357. https://doi.org/10.1159/000546539

Vancouver

Eto A, Endo A, Yoshida T, Seki Y, Taguchi K, Hongo M, et al. Videoconference-Based Cognitive Behavioral Therapy in Medication-Treated Adults with Attention-Deficit/Hyperactivity Disorder: A Randomized, Assessor-Blinded, Controlled Trial. Psychotherapy and Psychosomatics. 2025;94(5):343-357. doi:10.1159/000546539

BibTeX
@article{Eto2025,
  author = {Eto, Aiko and Endo, Ayumu and Yoshida, Tokiko and Seki, Yoichi and Taguchi, Kayoko and Hongo, Minako and Takahashi, Kohei and Shiko, Yuki and Hirano, Yoshiyuki and Shimizu, Eiji},
  title = {Videoconference-Based Cognitive Behavioral Therapy in Medication-Treated Adults with Attention-Deficit/Hyperactivity Disorder: A Randomized, Assessor-Blinded, Controlled Trial},
  journal = {Psychotherapy and Psychosomatics},
  year = {2025},
  volume = {94},
  number = {5},
  pages = {343--357},
  doi = {10.1159/000546539}
}
Kostenlos starten →